10 likes | 139 Views
Universidad Autónoma de Nuevo León Hospital Universitario Dr. José E. González” Servicio de Geriatría. “Cognitive Decline and Geriatric Assessment in a Mexican University Geriatric Unit”. Gámez Daniel M.D. González Blanca M.N. Salinas Ricardo M.D.
E N D
Universidad Autónoma de Nuevo León Hospital Universitario Dr. José E. González” Servicio de Geriatría “Cognitive Decline and Geriatric Assessment in a Mexican University Geriatric Unit” Gámez Daniel M.D. González Blanca M.N. Salinas Ricardo M.D. Presented: on July 8th 2009 IAGG Congress Paris 2009 Introduction: Cognitive decline has been associated with several diseases during the ageing process, for primary care clinicians there are some barriers to evaluate an elderly patient using the MMSE screening test, due to the multiple pathologies that have been involved. Methods and Materials: This is an observational and retrospective analysis from the database obtained during a 6 month period in the Geriatric Unit of the University Hospital U.A.N.L.; we analyzed 1311 ambulatory patients over 60 years of age from February to July 2008 and a MMSE evaluation was carried out during the first visit. A frequency and Chi square tests were performed using SPSS 13. Results: We obtained 372 males, 936 females, the mean of age was 75.97 years old and 4.44 the mean of level of education. The correlation showed depression and dementia as the principal cause of cognitive decline. Depression was a frequent diagnosis in all processes of cognitive decline with 139 patients (36.1%) in MMSE 26-30, 81 (35.4%) in MMSE 22 to 25, 117 (45.5%) with MMSE 17-21, 124 (46.6%) and finally 47 (55.3%) in MMSE 0 to 10. Alzheimer’s disease was the most frequent diagnosis of dementia and its prevalence increased during the cognitive decline process: 9 patients (2.5%) with MMSE 26 to 30, 9 (3.9%) with MMSE 22-25, 37 (14.4%) with MMSE 17-21, 85 (31.8%) with MMSE 11-16 and 35 (41.2%) with MMSE 0-10. Conclusion: MMSE is a screening test in the geriatric assessment and can be used by medical practitioners to evaluate cognitive decline but never to diagnose or to start treatment. The patients may be sent to specialized centers for the memory study to improve the diagnosis´ quality and intervention.